These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16370067)

  • 1. Doctors, drug companies and medical ethics: a Sri Lankan perspective.
    Malavige GN
    Indian J Med Ethics; 2004; 1(1):26. PubMed ID: 16370067
    [No Abstract]   [Full Text] [Related]  

  • 2. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 5. Can the relationship between doctors and drug companies ever be a healthy one?
    D'Arcy E; Moynihan R
    PLoS Med; 2009 Jul; 6(7):e1000075. PubMed ID: 19621069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
    Cicero MX; Curi MB; Mercurio M
    Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
    [No Abstract]   [Full Text] [Related]  

  • 7. No more free lunches: doctors and journals in the South cut off drug companies at their peril.
    Ana J
    BMJ; 2003 Aug; 327(7410):341-2. PubMed ID: 12907496
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
    Lifshitz A; Halabe J; Jasso L; Frati A; Alva C; Arrieta Ó; Burgos R; Campillo C; Celis MÁ; de la Llata M; Domínguez J; Islas R; Moreno M; Plancarte R; Reyes A; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2016; 152(3):295-6. PubMed ID: 27335182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 10. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way C; Bohigian G; Gale A; Powell M; Hagan JC
    Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488
    [No Abstract]   [Full Text] [Related]  

  • 13. How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
    Wager E
    BMJ; 2003 May; 326(7400):1196-8. PubMed ID: 12775623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician-industry interactions: there is no such thing as a free lunch.
    Tsai HJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
    [No Abstract]   [Full Text] [Related]  

  • 15. US Senate committee investigates conflicts of interest in industry funded medical education.
    Tanne JH
    BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
    [No Abstract]   [Full Text] [Related]  

  • 16. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

  • 18. Doctors and drug companies--scrutinizing influential relationships.
    Campbell EG
    N Engl J Med; 2007 Nov; 357(18):1796-7. PubMed ID: 17978288
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell?
    Lichter PR
    Arch Ophthalmol; 2008 Nov; 126(11):1593-7. PubMed ID: 19001230
    [No Abstract]   [Full Text] [Related]  

  • 20. End of the free lunch?
    Gould M
    BMJ; 2008 Aug; 337():a1399. PubMed ID: 18728077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.